Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2005 Nov 15;41(10):1438-44.
doi: 10.1086/497134. Epub 2005 Oct 13.

Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection

Jan Jelrik Oosterheert  1 , Anton M van Loon, Rob Schuurman, Andy I M Hoepelman, Eelko Hak, Steven Thijsen, George Nossent, Margriet M E Schneider, Willem M N Hustinx, Marc J M Bonten
Affiliations
Randomized Controlled Trial

Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection

Jan Jelrik Oosterheert et al. Clin Infect Dis. .

Abstract

Background: Rapid diagnostic tests with a high sensitivity for lower respiratory tract infection (LRTI) could lead to improved patient care and reduce unnecessary antibiotic use and associated costs. Diagnostic yields, feasibility, and costs of real-time polymerase chain reaction (PCR) of nasopharyngeal and oropharyngeal swab specimens in the routine diagnostic work-up for LRTI were determined.

Methods: In a randomized controlled trial, nasopharyngeal and oropharyngeal swab specimens from patients admitted for antibiotic treatment of LRTI were evaluated by means of real-time PCR for respiratory viruses and atypical pathogens, as well as by conventional diagnostic procedures. Real-time PCR results for patients in the intervention group were reported to the treating physician; results for patients in the control group were not made available.

Results: A total of 107 patients (mean age [+/- standard deviation], 63.6+/-16.3 years) were included, of whom 55 were allocated to the intervention group. The pathogens detected most frequently were influenza virus (14 patients), Streptococcus pneumoniae (8), coronavirus (6), Staphylococcus aureus (5), and rhinoviruses (5). Real-time PCR increased the diagnostic yield from 23 cases (21% of patients) to 47 cases (43% of patients), compared with conventional diagnostic tests. The detection of viral pathogens by PCR was associated with the winter season, less infiltrates on chest radiographs, lower C-reactive protein levels, and shorter duration of symptoms. Use of real-time PCR results resulted in partial or total cessation of antibiotic treatment for 6 patients (11%; 95% confidence interval, 2-19), but overall antibiotic use was comparable in the intervention group and the control group (median duration of treatment, 10.0 vs. 9.0 days; P=not significant). Use of real-time PCR increased treatment and diagnostic costs with 318.17 per patient.

Conclusions: Implementation of real-time PCR for the etiological diagnosis of LRTI increased the diagnostic yield considerably, but it did not reduce antibiotic use or costs.

PubMed Disclaimer

Figures

Table 1
Table 1
Characteristics of patients with lower respiratory tract infection (LRTI) in a study to detect viral and atypical bacterial pathogens by real-time PCR.
Table 2
Table 2
Results of etiologic investigations for patients with lower respiratory tract infection in a study to detect viral and atypical bacterial pathogens by real-time PCR.
Table 3
Table 3
Multivariate logistic regression analysis to detect characteristics associated with positive PCR results in patients with lower respiratory tract infection (LRTI).
Table 4
Table 4
Economical outcome associated with hospitalization, diagnostic procedures, and treatment for lower respiratory tract infection.
See this image and copyright information in PMC

Comment in

References

    1. Pneumonia and influenza death rates—United States, 1979–1994. MMWR Morb Mortal Wkly Rep. 1995;44:535–7. - PubMed
    1. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J. 1997;10:1530–4. - PubMed
    1. Marston BJ, Plouffe JF, File TM, Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 1997;157:1709–18. - PubMed
    1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86. - PubMed
    1. Lieberman D, Schlaeffer F, Boldur I, et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax. 1996;51:179–84. - PMC - PubMed

Publication types

MeSH terms

Substances